MELD: The holy grail of organ allocation?

Journal of Hepatology

Volumn 42, Issue 1, 2005, Pages 16-20

  Freeman, Richard B ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE DELIVERY; HEALTH CARE NEED; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL ETHICS; ORGAN DONOR; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW;

HUMANS; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT;

EID: 11144319834     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.11.002     Document Type: Review

References (21)

1. R.B. Freeman, R.H. Weisner, A. Harper, S.V. McDairmid, J. Lake, and E.B. Edwards The New Liver Allocation System: moving towards evidence-based transplantation policy Liver Transpl 8 2002 851 858
2. C.G. Child II, and J.G. Turcotte Surgery and portal hypertension C.G. Child II The liver and portal hypertension 1964 Saunders Philadelphia, PA 50 58
3. R.B. Freeman, and E.B. Edwards Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy Liver Transpl 6 2000 543 552
4. Organ procurement and transplantation: assessing current policies and the potential impact of the DHHS final rule. National Academy Press: Washington, DC; 1999, p 6.
5. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and P.L. ter-Borg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
6. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
7. R.H. Wiesner, E.B. Edwards, R.B. Freeman, A. Harper, R. Kim, and P. Kamath Model for end stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 2003 91 96
8. R.H. Wiesner, S.V. McDairmid, P.S. Kamath, B. Edwards, M. Malinchoc, and W.K. Kremers MELD and PELD: application of survival models to liver allocation Liver Transpl 7 2001 567 580
9. D.A. Stell, V.C. McAlistair, and D. Thorburn A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States Liver Transpl 10 2004 898 902
10. R.B. Freeman Waiting list mortality risk (and/or other measures) as the basis for allocation: MELD and PELD in liver allocation Plenary Presentation Am Transpl Congr 2004
11. R.A. Wolfe Efficient liver allocation Am J Transpl 2004 [in press]
12. R.M. Merion, R.B. Wolfe, R.H. Weisner, R.B. Freeman, F. Port, and D.M. Dykstra Lifetime benefit for liver transplantation Am J Transpl 2004 in press
13. R.B. Freeman MELD/PELD: where are we and where are we going? Am J Transpl 2004 [in press]
14. R.B. Freeman MELD and liver allocation: continuous quality improvement Hepatology 40 2004 787 789
15. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
16. A.E. Ruf, S.E. Yantorno, V.I. Descalzi, O.C. Andriani, L.G. Podesta, and F.G. Vilamil Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone - a single center experience Am J Transpl 4 2004 438
17. D.M. Heuman, S.G. Abou-assi, L.M. Williams, R.T. Stravitz, A.J. Sanyal, and R.A. Fisher Persistent ascites and low serum sodium identify cirrhotic with low Model for End Stage Liver Disease (MELD) scores who are at risk for early death Hepatology 2004 in press
18. V. Mazzaferro, E. Regalio, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
19. S.J. Cheng, R.B. Freeman, and J.B. Wong Predicting the probability of progression free survival in patients with small hepatocellular carcinoma Liver Transpl 8 2002 323 328
20. F.W. Yao, N.M. Bass, B. Nikolai, T.J. Davern, R. Kerlan, and V. Wu Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 2002 873 883
21. J.S. Lee, I.S. Chu, J. Heo, D.F. Calvisi, Z. Sun, and T. Roskams Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676